Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FYGF5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $351,504
Award facts
- Contract value 100% obligated
- $351,504.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $351,504.05 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Dupixent (dupilumab) is a biologic medication indicated for the treatment of moderate-to-severe eczema, asthma, and other inflammatory conditions, making this delivery order part of DLA's broader pharmaceutical supply chain supporting military and federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, leverages its comprehensive IDC vehicle to supply a wide range of brand-name and generic medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order reflects the company's established capability to fulfill federal medical procurement requirements through competitive open competition and demonstrates the continued reliance on its extensive global pharmaceutical support capabilities.
Quick answers
Who was awarded contract SPE2DB25FYGF5?
SPE2DB25FYGF5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FYGF5 worth?
The government has obligated $351,504 on SPE2DB25FYGF5.
Is contract SPE2DB25FYGF5 an order under another contract?
Yes. SPE2DB25FYGF5 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYGF5 competed?
The extent of competition for SPE2DB25FYGF5 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award